Pipeline栓塞装置治疗大脑中动脉动脉瘤:69例连续患者单中心经验
本研究回顾性分析2016年6月至2021年12月单中心连续69例大脑中动脉动脉瘤患者接受Pipeline栓塞装置(PED)治疗的数据,平均年龄47.4岁,女性42.0%。末次造影随访平均19.0±13.5个月时,56个动脉瘤中44个(78.6%)完全闭塞,10例(17.9%)出现支架内狭窄,3例(5.4%)出现大脑中动脉闭塞;平均临床随访35.1个月期间,63例中10例(15.8%)发生主要操作相关并发症,包括2例(3.2%)出血和8例(12.7%)缺血事件。作者认为PED是大脑中动脉动脉瘤的可行治疗选择,尤其适用于梭形和宽颈动脉瘤,临床结局和闭塞率良好,但并发症和支架内再狭窄风险值得注意,因此需谨慎选择患者。
要点
- PED治疗大脑中动脉动脉瘤末次造影随访完全闭塞率78.6%(44/56),支架内狭窄17.9%(10例),大脑中动脉闭塞5.4%(3例)。
- 主要操作相关并发症15.8%(10/63),其中出血3.2%(2例)、缺血12.7%(8例)。
- 作者认为PED对梭形和宽颈大脑中动脉动脉瘤可行,但并发症和支架内再狭窄风险值得注意,需谨慎选择患者。
核心结论
- PED是大脑中动脉动脉瘤的可行治疗选择,尤其适用于对传统开放手术具有挑战性的梭形和宽颈动脉瘤;PED显示出良好的临床结局和闭塞率,但存在值得注意的并发症和支架内再狭窄风险,因此使用PED治疗大脑中动脉动脉瘤时谨慎选择患者至关重要。
研究设计与样本
- 单中心连续病例系列,纳入2016年6月至2021年12月接受PED治疗的大脑中动脉动脉瘤患者69例,收集患者人口学特征、动脉瘤特征、操作细节、围手术期并发症及临床和造影随访结果。
关键影像表现/征象
- 共69例患者(平均年龄47.4岁;女性42.0%)纳入研究,其中5个动脉瘤既往破裂,10例患者既往接受过开放手术或血管内治疗。
- 末次造影随访平均19.0±13.5个月,56个动脉瘤中44个(78.6%)达到完全闭塞。
- 10例(17.9%)患者出现支架内狭窄,3例(5.4%)患者出现大脑中动脉闭塞。
临床应用与阅片要点
- 作者认为PED是大脑中动脉动脉瘤的可行治疗选择,尤其适用于对传统开放手术具有挑战性的梭形和宽颈动脉瘤。
- 作者指出PED存在值得注意的并发症和支架内再狭窄风险,因此使用PED治疗大脑中动脉动脉瘤时谨慎选择患者至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The pipeline embolization device (PED) has been established as an effective treatment option for aneurysms within its designated indications. Recently, its off-label applications, including treating middle cerebral artery (MCA) aneurysms, have increased. This study augmented the current literature by examining the outcomes of PED utilization for MCA aneurysms.
METHODS: We collected data from consecutive patients with MCA aneurysms treated with PED between June 2016 and December 2021. Particularly, we collected data on patient demographics, aneurysm characteristics, procedural details, perioperative complications, and clinical and angiographic follow-up results.
RESULTS: A total of 69 patients (mean age 47.4 years; 42.0% female) with MCA aneurysms who underwent PED treatment were included in this study. Among these, 5 aneurysms had ruptured previously, and 10 patients had previously undergone open surgery or received endovascular treatment. In the last angiographic follow-up, conducted at a mean of 19.0 ± 13.5 months, 44 of 56 (78.6%) aneurysms achieved complete occlusion. Ten (17.9%) and three (5.4%) patients exhibited in-stent stenosis and MCA occlusion, respectively. During a mean clinical follow-up period of 35.1 months, 10 of 63 patients (15.8%) experienced major procedure-related complications, including 2 hemorrhagic (3.2%) and 8 ischemic (12.7%) events.
CONCLUSION: PED is a viable treatment for MCA aneurysms, particularly those with fusiform and wide-necked characteristics that pose challenges for traditional open surgery. PED shows favorable clinical outcomes and occlusion rates and presents a notable risk of complications and in-stent restenosis. Therefore, careful patient selection is crucial when using PEDs to treat MCA aneurysms.
引用
- Zhu H, Zhang J, Liu L, et al. Pipeline embolization device in treating middle cerebral artery aneurysms: a single-center experience in 69 consecutive patients. Neuroradiology. 2025. PMID: 40192847. doi:10.1007/s00234-025-03606-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。